On the morning of the 29th, Cellics shares plunged to the daily lower limit in the domestic stock market, showing a sharp contraction in investor sentiment. Meanwhile, Jinhung Co. Preferred B and Jinhung Co. 2nd Preferred B, which had hit the daily lower limit in the previous session, broke out of the limit and somewhat eased their declines.

That morning, profit-taking sell-offs and selling pressure concentrated on Cellics, widening its losses from the opening to push the stock down to the price limit. It eventually entered the daily lower limit, drawing significant market attention.

On the other hand, Jinhung Co. Preferred B and Jinhung Co. 2nd Preferred B continued to exhibit high volatility, but showed a trend of moving away from the limit-down decline seen in the previous session.

Market analysts assessed that profit-taking orders were being placed mainly on stocks that had surged recently, maximizing price volatility depending on individual stock catalysts and supply-demand dynamics. In particular, preferred shares and biotech stocks were diagnosed as experiencing repeated short-term surges and plunges due to their small floating supply or sensitivity to changes in investor sentiment.

Experts advised that stocks experiencing rapid surges or plunges near the price limit carry extremely high volatility, and therefore investors should carefully review relevant disclosures, business operations, and investment risk factors before approaching them.

[This article was written with the assistance of AI. It was produced with partial support from AI in the writing process based on publicly available materials and was finalized after final editing and fact-checking. This article is not intended to solicit investment, and the final judgment and responsibility for investments rest with the investor.]